172 related articles for article (PubMed ID: 21426010)
1. Strategies for the treatment of dengue virus infections: a narrative account.
De Clercq E
Future Med Chem; 2010 Apr; 2(4):601-8. PubMed ID: 21426010
[TBL] [Abstract][Full Text] [Related]
2. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
[TBL] [Abstract][Full Text] [Related]
3. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses.
Lee E; Pavy M; Young N; Freeman C; Lobigs M
Antiviral Res; 2006 Jan; 69(1):31-8. PubMed ID: 16309754
[TBL] [Abstract][Full Text] [Related]
4. Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference.
Sze A; Olagnier D; Hadj SB; Han X; Tian XH; Xu HT; Yang L; Shi Q; Wang P; Wainberg MA; Wu JH; Lin R
Viruses; 2017 Oct; 9(10):. PubMed ID: 28972551
[TBL] [Abstract][Full Text] [Related]
5. An iminosugar with potent inhibition of dengue virus infection in vivo.
Perry ST; Buck MD; Plummer EM; Penmasta RA; Batra H; Stavale EJ; Warfield KL; Dwek RA; Butters TD; Alonzi DS; Lada SM; King K; Klose B; Ramstedt U; Shresta S
Antiviral Res; 2013 Apr; 98(1):35-43. PubMed ID: 23376501
[TBL] [Abstract][Full Text] [Related]
6. The search for nucleoside/nucleotide analog inhibitors of dengue virus.
Chen YL; Yokokawa F; Shi PY
Antiviral Res; 2015 Oct; 122():12-9. PubMed ID: 26241002
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of lanatoside C against dengue virus infection.
Cheung YY; Chen KC; Chen H; Seng EK; Chu JJ
Antiviral Res; 2014 Nov; 111():93-9. PubMed ID: 25251726
[TBL] [Abstract][Full Text] [Related]
8. Strategies for development of Dengue virus inhibitors.
Noble CG; Chen YL; Dong H; Gu F; Lim SP; Schul W; Wang QY; Shi PY
Antiviral Res; 2010 Mar; 85(3):450-62. PubMed ID: 20060421
[TBL] [Abstract][Full Text] [Related]
9. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
10. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
Melino S; Paci M
FEBS J; 2007 Jun; 274(12):2986-3002. PubMed ID: 17509079
[TBL] [Abstract][Full Text] [Related]
11. Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.
Parkinson T; Pryde DC
Future Med Chem; 2010 Jul; 2(7):1181-203. PubMed ID: 21426163
[TBL] [Abstract][Full Text] [Related]
12. Novel 2-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,3,4-oxadiazole and 3-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,2,4-oxadiazole derivatives as dengue virus inhibitors targeting NS5 polymerase.
Benmansour F; Eydoux C; Querat G; de Lamballerie X; Canard B; Alvarez K; Guillemot JC; Barral K
Eur J Med Chem; 2016 Feb; 109():146-56. PubMed ID: 26774922
[TBL] [Abstract][Full Text] [Related]
13. 3-O-sulfated glucuronide derivative as a potential anti-dengue virus agent.
Hidari KI; Ikeda K; Watanabe I; Abe T; Sando A; Itoh Y; Tokiwa H; Morita K; Suzuki T
Biochem Biophys Res Commun; 2012 Aug; 424(3):573-8. PubMed ID: 22776202
[TBL] [Abstract][Full Text] [Related]
14. Targeting a host process as an antiviral approach against dengue virus.
Sayce AC; Miller JL; Zitzmann N
Trends Microbiol; 2010 Jul; 18(7):323-30. PubMed ID: 20452219
[TBL] [Abstract][Full Text] [Related]
15. Looking for inhibitors of the dengue virus NS5 RNA-dependent RNA-polymerase using a molecular docking approach.
Galiano V; Garcia-Valtanen P; Micol V; Encinar JA
Drug Des Devel Ther; 2016; 10():3163-3181. PubMed ID: 27784988
[TBL] [Abstract][Full Text] [Related]
16. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell.
Talarico LB; Pujol CA; Zibetti RG; Faría PC; Noseda MD; Duarte ME; Damonte EB
Antiviral Res; 2005 Jun; 66(2-3):103-10. PubMed ID: 15911027
[TBL] [Abstract][Full Text] [Related]
17. The medicinal chemistry of dengue fever.
Stevens AJ; Gahan ME; Mahalingam S; Keller PA
J Med Chem; 2009 Dec; 52(24):7911-26. PubMed ID: 19739651
[No Abstract] [Full Text] [Related]
18. Development of a broad-spectrum antiviral with activity against Ebola virus.
Aman MJ; Kinch MS; Warfield K; Warren T; Yunus A; Enterlein S; Stavale E; Wang P; Chang S; Tang Q; Porter K; Goldblatt M; Bavari S
Antiviral Res; 2009 Sep; 83(3):245-51. PubMed ID: 19523489
[TBL] [Abstract][Full Text] [Related]
19. Identification of a small-molecule inhibitor of dengue virus using a replicon system.
Hsu YC; Chen NC; Chen PC; Wang CC; Cheng WC; Wu HN
Arch Virol; 2012 Apr; 157(4):681-8. PubMed ID: 22249364
[TBL] [Abstract][Full Text] [Related]
20. Structure elucidation and sulfated derivatives preparation of two alpha-D-glucans from Gastrodia elata Bl. and their anti-dengue virus bioactivities.
Qiu H; Tang W; Tong X; Ding K; Zuo J
Carbohydr Res; 2007 Nov; 342(15):2230-6. PubMed ID: 17637459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
